SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 27.44-0.3%9:38 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: steve dietrich who wrote (334)1/15/1997 7:22:00 AM
From: Mike Relyea   of 1693
 
Regarding Procter & Gable's partnering agreement, an Astra spokesman said that Procter & Gamble will certainly be able to sell on the enormous H. pylori market, but it does not worry us....Astra still expects Losec to become the biggest selling drug in the U.S. in 1997."

Just wait till Wall Street begins to comprehend the meaning of "enormous" and "biggest selling," as they relate to H. pylori!

biz.yahoo.com

ChemTrak assigned the U.S. marketing rights for its H. pylori test to Astra Merck Inc.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext